Verisante Technology Inc.

FRC's fair value estimate for Verisante Technology Inc., and the rating behind it. VRSEF last traded at $0.0096, 0.6× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Verisante Technology Inc.. Starting points for Verisante Technology Inc.: P/E 0.6, beta 4.44 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Verisante Technology Inc.. Verisante Technology Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Verisante Technology Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Verisante Technology Inc.. Verisante Technology Inc. has reported as a listed company since 2011. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Verisante Technology Inc. valued side by side against its closest peers. Verisante Technology Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Verisante Technology Inc., and how their positions are changing. At a $1.4M market value, institutional positions materially move Verisante Technology Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Verisante Technology Inc. executives and directors. Shares of Verisante Technology Inc. have traded between $0.0002 and $0.01 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Verisante Technology Inc.. Verisante Technology Inc. is a $1.4M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Verisante Technology Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Verisante Technology Inc.. Coverage tracks Verisante Technology Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.